Anti-Diabetic Medications to Fight PD and LBD

Summary

The purpose of this study is to test the hypothesis that DPP4 inhibitors and SGLT2 inhibitors are well tolerated and have beneficial neurological effects, specifically for Parkinson's disease and Lewy body dementia.

Timeline

Start

2024-05-07

Primary completion

2025-01-08

Completion

2025-01-08

Publications

• Chmiela T, Dulski J, Heckman MG, Fang ZJ, Wszolek ZK, Wilson JR. Anti-diabetic medications to fight Parkinson's disease and dementia with Lewy bodies: a pilot study. Front Neurol. 2026 May 29;17:1825229. doi: 10.3389/fneur.2026.1825229. eCollection 2026.

Drugs

Indications